Bausch Health Companies Inc has seen some movement in the stock market this week, with a notable focus on recent product announcements.
This week, Bausch Health Companies Inc (BHC.TO) experienced a slight decline in price, closing at C$9.06, down 2.79% on the day. Despite this, the stock has seen a weekly gain of 3.19%. Investors are paying attention to recent announcements regarding product availability, which may influence future performance.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.39B
52W high
$11.08
52W low
$6.10
1W change
+3.19%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 22.6% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-22.6% Upside
Current Price
C$9.06
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
96.1%
Annualized
90-Day Vol
66.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.83
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.62 | C$6.90 – C$13.40 |
| 60 trading days | C$10.21 | C$6.39 – C$16.31 |
| 90 trading days | C$10.83 | C$6.10 – C$19.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Bausch Health's recent announcements may provide some optimism, the stock's overall bearish outlook from analysts suggests caution for investors.
C$9.06 closing price with a weekly gain of 3.19%
The stock's volume was significantly lower than its 20-day average, indicating reduced trading activity.
Bull case
The launch of Solta Medical's Fraxel FTX® in Australia could strengthen Bausch Health's market presence and open up new revenue opportunities.
Bear case
Despite recent gains, investors should be cautious due to a negative profit margin and bearish outlooks from analysts regarding the stock's long-term performance.
Recent Company News
Bausch Health has announced the availability of Solta Medical's Fraxel FTX® in Australia, which is expected to enhance their product line in the dermatology sector. This news was released multiple times over the past week, indicating a strategic push to expand their offerings internationally. Additionally, Bausch Health's Ortho Dermatologics division announced the 2026 Aspire Higher Scholarship winners, further showcasing their commitment to community engagement.
Advertisement
Technical Picture
As of the latest close, Bausch Health's stock price of C$9.06 is above both its 50-day moving average of C$7.92 and its 200-day moving average of C$8.09, suggesting a short-term bullish trend. The stock has fluctuated within a 52-week range of C$6.10 to C$11.08, currently sitting at 59% of that range. With a beta of 0.37, the stock is considered less volatile compared to the market. However, the trading volume of 227,423 shares is significantly lower than the 20-day average of 742,804 shares, indicating decreased investor interest recently.
Insider Activity
No recent insider activity has been reported for Bausch Health Companies Inc, which could indicate a lack of significant changes in ownership or confidence from those closest to the company.
Analyst Outlook
Analysts maintain a bearish outlook on Bausch Health, with an average target price of C$7.01, implying a potential downside of 22.6% from the current price. With a negative profit margin of -10.1% and a return on equity of 43.6%, the company's financial health presents challenges that may weigh on future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
